Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
Norgestrel and Ethinyl Estradiol Tablets USP (RLD Lo/Ovral-28) had an estimated annual sale of USD 34 million in the U.S. (IQVIA MAT Mar 2023)
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
Subscribe To Our Newsletter & Stay Updated
